Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OCSL | GSBD |
|---|---|---|
| Price | $11.65 | $8.81 |
| Change today | ▼ 0.43% | ▼ 2.44% |
| Market cap | $1.03B | $991.73M |
| Return, 3 months | +1.0% | +7.0% |
| Return, year to date | +0.2% | +6.0% |
| Return, 1 year | +4.0% | +4.7% |
| P/E (TTM) | 24.3 | 16.9 |
| P/B | 0.7 | 0.7 |
| P/E percentile vs own 5y | 62nd | 64th |
| Dividend yield | 13.22% | 15.66% |
| Revenue growth (YoY, latest qtr) | -5.1% | -36.7% |
| Net profit growth (YoY) | -19.3% | -39.7% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 78.9% | 82.3% |
| Return on equity | 3.0% | 4.1% |
| Analyst target vs. price | +9.4% | +2.2% |
| Analyst buy share | 0% | 0% |
| RSI (14) | 32 | 33 |
| 30-day volatility | 15.0% | 19.7% |
| Max drawdown, 1 year | -19.5% | -13.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
